Arthur Toga Selected Research

Apolipoproteins E (ApoE)

11/2023	Profiling baseline performance on the Longitudinal Early-Onset Alzheimer's Disease Study (LEADS) cohort near the midpoint of data collection.
11/2023	Sex and APOE ε4 carrier effects on atrophy, amyloid PET, and tau PET burden in early-onset Alzheimer's disease.
1/2021	The Impact of Amyloid Burden and APOE on Rates of Cognitive Impairment in Late Life Depression.
1/2021	Late-Life Depression Is Associated With Reduced Cortical Amyloid Burden: Findings From the Alzheimer's Disease Neuroimaging Initiative Depression Project.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Arthur Toga Research Topics

Disease

10	Alzheimer Disease (Alzheimer's Disease) 11/2023 - 05/2010
7	Cognitive Dysfunction 11/2023 - 05/2010
5	Dementia (Dementias) 11/2023 - 07/2020
3	Atrophy 11/2023 - 05/2010
2	Traumatic Brain Injuries (Traumatic Brain Injury) 01/2021 - 01/2019
2	Frontotemporal Lobar Degeneration (Degeneration, Frontotemporal Lobar) 01/2020 - 01/2020
1	Breast Neoplasms (Breast Cancer) 10/2022
1	Subdural Hematoma (Subdural Hemorrhage) 01/2021
1	Neuroinflammatory Diseases 01/2021
1	Contusions 01/2021
1	Hematoma 01/2021
1	Inflammation (Inflammations) 01/2021
1	Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage) 01/2021
1	Neurobehavioral Manifestations 01/2021
1	Intracranial Hemorrhages (Intracranial Hemorrhage) 01/2021
1	Frontotemporal Dementia (Semantic Dementia) 01/2020
1	Hypersensitivity (Allergy) 01/2020
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2020
1	Epilepsy (Aura) 01/2019
1	Post-Traumatic Epilepsy (Epilepsy, Post Traumatic) 01/2019
1	Brain Concussion (Cerebral Concussion) 01/2018
1	Craniocerebral Trauma (Head Injury) 01/2018

Drug/Important Bio-Agent (IBA)

10	Biomarkers (Surrogate Marker)IBA 11/2023 - 05/2010
8	Amyloid (Amyloid Fibrils)IBA 11/2023 - 01/2021
4	Apolipoproteins E (ApoE)IBA 11/2023 - 01/2021
3	Amyloid beta-PeptidesIBA 11/2023 - 05/2010
1	4- (N- methylamino)- 4'- (2- (2- (2- fluoroethoxy)ethoxy)ethoxy)stilbeneIBA 11/2023
1	ApolipoproteinsIBA 11/2023
1	7- (6- fluoropyridin- 3- yl)- 5H- pyrido(4,3- b)indoleIBA 11/2023
1	Trastuzumab (Herceptin)FDA Link 10/2022
1	A-factor (Streptomyces)IBA 01/2021
1	ORALIT (ORS)IBA 01/2021
1	Apolipoprotein E4IBA 01/2021
1	AD 20 (AD-20)IBA 10/2020
1	Transcription Factors (Transcription Factor)IBA 01/2020
1	ProgranulinsIBA 01/2020
1	Deoxyribonucleases (DNase)FDA Link 01/2020
1	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 01/2020
1	2- (4'- (methylamino)phenyl)- 6- hydroxybenzothiazole (Pittsburgh compound B)IBA 05/2010

Therapy/Procedure

3	Therapeutics 01/2021 - 01/2019
1	CPDD protocol 07/2020
1	Aftercare (After-Treatment) 01/2018